triamcinolone has been researched along with Glaucoma, Neovascular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hammer, T; Sietmann, R; Wilhelm, A; Wilhelm, U | 1 |
| Jager, MJ; Missotten, GS; Schlingemann, RO | 1 |
| Blodi, BA; Chan, CK; Ip, MS; Oden, NL; Scott, IU; Tolentino, MJ; Vanveldhuisen, PC | 1 |
| Collignon, NJ; Collignon-Brach, J; Crommen, J; Rakic, JM | 1 |
1 trial(s) available for triamcinolone and Glaucoma, Neovascular
| Article | Year |
|---|---|
SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.
Topics: Aged; Capillaries; Female; Glaucoma, Neovascular; Glucocorticoids; Humans; Incidence; Iris; Ischemia; Light Coagulation; Linear Models; Male; Neovascularization, Pathologic; Retinal Hemorrhage; Retinal Neovascularization; Retinal Vein Occlusion; Retinal Vessels; Risk Assessment; Triamcinolone; Vitreous Hemorrhage | 2011 |
3 other study(ies) available for triamcinolone and Glaucoma, Neovascular
| Article | Year |
|---|---|
[The influence of VEGF inhibitors on corneal endothelium after injection into the anterior chamber in a porcine eye model].
Topics: Angiogenesis Inhibitors; Animals; Anterior Chamber; Bevacizumab; Corneal Endothelial Cell Loss; Disease Models, Animal; Endothelium, Corneal; Glaucoma, Neovascular; Injections, Intraocular; Intraocular Pressure; Ranibizumab; Swine; Triamcinolone; Vascular Endothelial Growth Factor A | 2015 |
Angiogenesis and vascular endothelial growth factors in intraocular tumors.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chronic Disease; Eye Neoplasms; Glaucoma, Neovascular; Glucocorticoids; Humans; Inflammation; Injections, Intraocular; Neovascularization, Pathologic; Radiation Injuries; Ranibizumab; Retinal Diseases; Triamcinolone; Vascular Endothelial Growth Factor A | 2010 |
[Low dose intravitreal triamcinolone acetonide in the treatment of neovasular glaucoma].
Topics: Aged; Aged, 80 and over; Female; Glaucoma, Neovascular; Glucocorticoids; Humans; Injections; Male; Middle Aged; Triamcinolone; Vitreous Body | 2005 |